Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Case 20: - The pregnancy blues
Published online by Cambridge University Press: 03 April 2024
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Summary
Exposure to selective serotonin reuptake inhibitors (SSRIs) during pregnancy increases the risk of which of the following?
Keywords
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 345 - 362Publisher: Cambridge University PressPrint publication year: 2024
References
Branquinho, M, Rodriguez-Muñoz, MF, Maia, BR, et al. Effectiveness of psychological interventions in the treatment of perinatal depression: a systematic review of systematic reviews and meta-analyses. J Affect Disord 2021; 291:294–306CrossRefGoogle ScholarPubMed
Brooks, E, Cox, E, Kimmel, M, et al. Risk of Untreated Symptoms of PMADs in Pregnancy and Lactation. Cham, Switzerland: Springer, 2021, 45–54Google Scholar
Byatt, N, Deligiannidis, KM, Freeman, MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand 2013; 127:94–114CrossRefGoogle ScholarPubMed
Chad, L, Pupco, A, Bozzo, P, et al. Update on antidepressant use during breastfeeding. Can Fam Physician 2013; 59:633–4Google ScholarPubMed
Dean, L, Kane, M. Aripiprazole therapy and CYP2D6 genotype. Sept. 22, 2016 [Updated Feb. 10, 2021]. In: Pratt VM, Scott SA, Pirmohamed M, et al. (eds.) Medical Genetics Summaries [internet]. Bethesda, MD): National Center for Biotechnology Information (US); 2012– ; www.ncbi.nlm.nih.gov/books/NBK385288Google Scholar
Deligiannidis, KM, Freeman, MP. Complementary and alternative medicine therapies for perinatal depression. Best Pract Res Clin Obstet Gynaecol 2014; 28:85–95CrossRefGoogle ScholarPubMed
El Marroun, H, Jaddoe, VW, Hudziak, JJ, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012; 69:706–14CrossRefGoogle ScholarPubMed
Eléfant, E, Hanin, C, Cohen, D. Pregnant women, prescription, and fetal risk. Handb Clin Neurol 2020; 173:377–89CrossRefGoogle ScholarPubMed
Gadot, Y, Koren, G. The use of antidepressants in pregnancy: focus on maternal risks. J Obstet Gynaecol Can 2015; 37:56–63Google ScholarPubMed
Galbally, M, Lewis, AJ, Buist, A. Developmental outcomes of children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry 2011; 45:393–9CrossRefGoogle ScholarPubMed
Hashmi, AM, Bhatia, SK, Bhatia, SK, et al. Insomnia during pregnancy: diagnosis and rational interventions. Pak J Med Sci 2016; 32:1030–7Google ScholarPubMed
Huybrechts, KF, Bateman, BT, Palmsten, K, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA 2015; 313:2142–51CrossRefGoogle ScholarPubMed
Huybrechts, KF, Palmsten, K, Avorn, J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014; 370:2397–407CrossRefGoogle ScholarPubMed
Kjaersgaard, MIS, Parner, ET, Vestergaard, M, et al. Prenatal antidepressant exposure and risk of spontaneous abortion – a population-based study. PLoS One 2013; 8:e72095CrossRefGoogle ScholarPubMed
Lee, HJ, Kim, SM, Kwon, JY. Repetitive transcranial magnetic stimulation treatment for peripartum depression: systematic review & meta-analysis. BMC Pregnancy and Childbirth 2021; 21:118CrossRefGoogle ScholarPubMed
Levinson-Castiel, R, Merlob, P, Linder, N, et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173–6CrossRefGoogle ScholarPubMed
Lomonaco-Haycraft, KC, Hyer, J, Tibbits, B, et al. Integrated perinatal mental health care: a national model of perinatal primary care in vulnerable populations. Prim Health Care Res Dev 2018; 20:e77CrossRefGoogle ScholarPubMed
Malm, H, Brown, AS, Gissler, M, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study. J Am Acad Child Adolesc Psychiatry 2016; 55:359–66Google ScholarPubMed
Nelson, JC, Pikalov, A, Berman, RM. Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatr Dis Treat 2008; 4:937–48Google ScholarPubMed
Osborne, L, Birndorf, C. Depressive Disorders. Arlington, VA: American Psychiatric Publishing, Inc., 2022.Google Scholar
Patorno, E, Huybrechts, KF, Bateman, BT, et al. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 2017; 376:2245–54. https://doi.org/10.1056/NEJMoa1612222CrossRefGoogle ScholarPubMed
Payne, JL. Psychopharmacology in pregnancy and breastfeeding. Psychiatr Clin North Am 2017; 40:217–38CrossRefGoogle ScholarPubMed
Payne, JL. Psychopharmacology in pregnancy and breastfeeding. Med Clin North Am 2019; 103:629–50CrossRefGoogle ScholarPubMed
Rommel, AS, Momen, NC, Molenaar, NM, et al. Antidepressant use during pregnancy and risk of adverse neonatal outcomes: a comprehensive investigation of previously identified associations. Acta Psychiatr Scand 2022; 145:544–56CrossRefGoogle ScholarPubMed
Ross, LE, Grigoriadis, S, Mamisashvili, L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 2013; 70:436–43CrossRefGoogle ScholarPubMed
Van den Bergh, BR, Van Calster, B, Smits, T, et al. Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 2008; 33:536–45Google ScholarPubMed
Ward, HB, Fromson, JA, Cooper, JJ, et al. Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol. Arch Womens Ment Health 2018; 21:715–22Google ScholarPubMed
Wisner, KL, Bogen, DL, Sit, D, et al. Does fetal exposure to SSRIs or maternal depression impact infant growth? Am J Psychiatry 2013; 170:485–93CrossRefGoogle ScholarPubMed
Yonkers, KA, Norwitz, ER, Smith, MV, et al. Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology 2012; 23:677–85CrossRefGoogle ScholarPubMed